There were no changes to Prescriptions in this release.

There were no changes to Prescriptions in this release.

Enhancements to Cost Predictions

The Cost prescriptions interface has been enhanced to make the results of Cost prescriptions easier to understand at a glance. Changes include:

• The Run Options for Cost Prescriptions now support site groups and product groups. You can use these groups to exclude sites from Node Skipping, set Mode Switch Constraints for sites and products, and set Shipment Frequency Options for sites and products.

• The maps on the Prescriptions’ Detail page now include direction of flow indicators and tooltips to show the flow details.

Updated Node Skipping Detail page

Previously, the “Before Node Skipping was Applied” map and the “Affected Lanes” table included all lane changes for all products. This made it difficult to determine which lane changes affected which products. These visualizations will now display only the lane changes prescribed for the product selected in the Product Insights table.

Enhancements to Risk Prescriptions

The Risk Prescriptions interface has been enhanced to make the results of prescriptions easier to understand at a glance. Changes include:

• On the Network Risk Prescriptions page, new columns have been added to the grid to give the user a better idea of the effects of the prescription. The new columns are:

  • Is Current Top Site-Product?

  • Is Potential Top Site-Product?

  • # of Downstream changes

  • # of Upstream changes

• On the Network Risk Prescriptions page, the “Current Flow Quantity” and “Potential Flow Quantity” columns have been removed. These columns appear on the Prescriptions Detail page.

• On the Prescriptions Detail page, the “Current Network” and “Proposed Network” tables have been merged to create a single summary table for the prescription. This table includes a new “Change Type” column to indicate whether the prescription affects the flow upstream or downstream.

• On the Prescriptions Detail page, the maps now include direction of flow indicators and tooltips to show the flow details

Updated units of measure displayed in dashboards

Supply Chain Prescriptions now displays the appropriate labels for the units of measure that exist in your model (currency, distance, volume, etc). Previously, all labels were set to U.S. dollars, pounds, and miles.

Volume Consolidation improvements

The following improvements have been made to Volume Consolidation prescriptions:

• The Volume Consolidation algorithm has been improved and cost savings should increase.

• The Volume Consolidation algorithm now uses the cost calculator and the basis specified by the user within Volume Consolidation rather than using a “per mile per pound” basis. You can now choose to estimate cost based on units rather than weight. This is useful if the model doesn't have weight information.

Network Risk prescriptions added

In addition to the complexity of supply chains, they inherently involve risk. Recent years have highlighted that risk, as companies have struggled to overcome a variety of challenges to their supply chains. Single- and multi-point failures can lead to major disruptions of the supply chain, impacting corporate revenue and reputation. Modelers need to quantify and model risk in their supply chains as they work to make their supply chains more resilient and cost effective.

With the new Supply Chain Prescriptions Risk feature, you can mitigate the effects of potential single point failures that can lead to disruption of the supply chain network. The Risk app identifies sites and lanes that are critical from a revenue or value of goods flown perspective, and then generates constraints that must be imposed on the network to minimize the risk of those critical sites and lanes. The constraints correspond to various levels of risk. There are four types of prescriptions for Risk:

• Alternate supplier sites

• Alternate manufacturer sites

• Alternate distribution centers

• Flow shifts

These prescriptions can be reviewed by supply chain managers, who can accept or reject the prescriptions.

SCDP 36.3.0 Change to Node Skipping

Node Skipping prescriptions will now match “Source”, “Destination” and “Product” for a lane rather than just matching “Source” and “Destination”. If a lane matches the Source, Destination, and Product values of any flow constraint in Modeler, Prescriptions will “exclude” that flow constraint and include the prescription.

Change to the Web address for Supply Chain Prescriptions

The Web address for Supply Chain Prescriptions has been changed to us.llama.ai/prescriptions for U.S. customers and eu.llama.ai/prescriptions for E.U. customers.

Accepting and rejecting prescriptions (Prescriptions Lifecycle Management)

Users will now be able to accept or reject prescriptions according to the operational feasibility in their supply chains. This allows the Prescriptions engine to learn from the user what prescriptions are feasible or infeasible, and to generate more business-relevant prescriptions. The user can then spend less time reviewing prescriptions that are not relevant to their business.

The Supply Chain Prescriptions user is able to:

• Accept a prescription or a group of prescriptions

• Reject prescriptions in bulk due to quantity, potential savings, volume, and weight

• Access an archive that shows a list of criteria on which prescriptions were previously rejected

Updated Prescriptions Summary page

The Prescriptions Summary page has been enhanced to provide more information at a glance.

The Summary header now includes:

• The total number of prescriptions

• The total number of accepted prescriptions (once prescriptions have been accepted )

• The total accepted savings (once prescriptions have been accepted )

• A tooltip that describes the savings, including a summary of the number of prescriptions that have been accepted in the current run

The Summary page also now includes these enhancements:

• The Potential Savings by Prescription Type and Insights on Potential Savings charts are next to each other for easier viewing

• The Top Factors Increasing and Decreasing bar chart is now color coded by increasing and decreasing costs and the chart has been moved above the Top 10 Prescriptions grid

• The fixed bar chart labels are now available as tool tips. Hover over a chart bar to see the precise value for that bar

• The charts have been updated to include horizontal grid lines to make the charts easier to read

• The Summary page now appears when a run is completed so that the user can quickly see results.

Updated Prescriptive Insights pages

The Prescriptive Insights pages have been restructured to provide more information at a glance. These pages will now display the Prescriptions grid automatically. You can view the details for a prescription by clicking the prescription’s ID link.

For the Mode Switching and Volume Consolidation pages, you can view the Overview tab for the prescription type by clicking the Overview tab at the top of the page.

New “All Prescriptions” page

The “Export to Model” page has been renamed to “All Prescriptions”, and the prescriptions grid has been updated to include more information about each prescription. In particular, the grid now includes two new columns:

• The new Status column indicates if the prescription has been accepted, rejected, or not yet reviewed.

• The new Exported column indicates if the prescription has been exported to Modeler.

Prescriptions export enhancements

The Prescriptions export processes have been changed to only export prescriptions with a status of “Accepted” or “Unreviewed”.

Searching for projects and models

On the Prescriptions home page, the Search field can be used to search for a specific model as well as a project.